Received Feb 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | UNK | Y1A212M | OT / LA |
received 1mL instead of 0.5mL with no reported adverse event; Initial information received on 10-Feb-2026 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 5 years old female patient who had received IPV (Vero) [IPOL] dose of 1ml instead of 0.5ml with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Varicella zoster vaccine (Varicella vaccine) for Immunisation. On 10-Feb-2026, the patient received a 1 ml (dose 7) of suspect IPV (VERO) Suspension for injection (Strength: standard, lot Y1A212M, expiry date: 31-JAN-2027) via intramuscular route in the left deltoid as Immunization instead of 0.5ml with no reported adverse event (extra dose administered) (latency: same day). Reportedly, she was given the product too early several other times by another provider) IPV: 23FEB2021, 23APR2021 OPV: 23JUN2021, 11JUL2022, and 02SEP2022; PENTACEL: 12AUG2024. Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Varicella vaccine